Is PRP more effective than shockwave therapy?

Neither treatment is universally superior. Head-to-head studies show mixed results depending on the condition. For patellar tendinopathy, one well-known study found PRP slightly outperformed ESWT at long-term follow-up. For plantar fasciitis, the evidence is more balanced. Your provider can help determine which option has stronger evidence for your specific condition.

Can I get both PRP and shockwave therapy for the same injury?

Yes, some providers use them sequentially. A common approach is starting with ESWT and adding PRP if the response is insufficient. The treatments work through different mechanisms, so combining them is biologically plausible, though research on the combination is still limited.

Why is PRP so much more expensive than shockwave therapy?

PRP requires a blood draw, specialized centrifuge equipment, and processing time to concentrate the platelets. The procedure is more labor-intensive and uses consumable kits that add to the cost. ESWT uses a reusable device with no consumables beyond ultrasound gel, which keeps per-session costs lower.

Shockwave Therapy vs. PRP Injections

If you’ve been researching treatment options for a chronic tendon injury, two names keep appearing in the “regenerative medicine” category: extracorporeal shockwave therapy (ESWT) and platelet-rich plasma (PRP) injections. Both promise something different from cortisone or surgery – rather than masking pain or cutting tissue, they aim to stimulate your body’s own healing response. But they do this through very different mechanisms, and the evidence behind each varies by condition.

How Each Treatment Works

Shockwave therapy delivers acoustic pressure waves through the skin into damaged tissue. These high-energy pulses create controlled mechanical stress, triggering a cascade of biological responses: increased blood flow, growth factor release, stem cell recruitment, and new collagen production. The treatment is fully external – nothing enters the body.

PRP injections take a direct delivery approach. Your provider draws your blood, spins it in a centrifuge to concentrate the platelets (which contain growth factors), and injects the concentrated solution directly into the damaged tissue. The growth factors are delivered to the injury site in much higher concentrations than your blood normally carries.

The difference is indirect versus direct. ESWT triggers your tissue to produce its own growth factors. PRP delivers concentrated growth factors from your blood. Both aim for tissue repair, but through different biological pathways.

Comparing the Evidence

Both treatments have clinical research behind them, but the evidence base differs.

ESWT evidence is broader. Shockwave therapy has been studied in large randomized controlled trials (RCTs) for plantar fasciitis, lateral epicondylitis, Achilles tendinopathy, and calcific shoulder tendinitis. Multiple systematic reviews and meta-analyses support its effectiveness for these conditions. The body of evidence spans over two decades.

PRP evidence is growing but less consistent. PRP has shown promising results in some studies, but the evidence is complicated by a lack of standardization. Different centrifuge systems produce different PRP compositions (varying platelet concentrations, white blood cell content, and growth factor profiles). This variability makes it harder to draw firm conclusions across studies.

Head-to-Head Research

Direct comparison studies are limited but informative. A 2013 study by Vetrano and colleagues compared ESWT to PRP for patellar tendinopathy (jumper’s knee). Both groups improved significantly. At 6- and 12-month follow-up, the PRP group showed modestly better results, though both treatments produced meaningful improvement (Vetrano et al., 2013, American Journal of Sports Medicine).

For plantar fasciitis, a 2019 RCT found comparable outcomes between ESWT and PRP at 3 months, with no statistically significant difference between groups (Shetty et al., 2019, Foot and Ankle Surgery).

The takeaway: neither treatment is clearly superior across all conditions. The best choice often depends on the specific diagnosis.

Practical Differences

Beyond the science, the patient experience differs meaningfully.

Factor	Shockwave Therapy (ESWT)	PRP Injection
Invasiveness	Non-invasive (external)	Minimally invasive (needle injection + blood draw)
Session duration	15-30 minutes	45-60 minutes (including blood draw and processing)
Sessions needed	3-5 typically	1-3 typically
Pain during treatment	Moderate pressure/discomfort	Brief injection pain
Recovery after session	Minimal (avoid heavy loading 24-48 hrs)	Soreness at injection site for several days
Cost per session	$100-$500	$500-$2,000
Total course cost	$300-$1,500	$500-$4,000
Insurance coverage	Rarely covered	Rarely covered

Both treatments are typically out-of-pocket expenses. The cost difference can be significant – a full course of ESWT often costs less than a single PRP injection.

When ESWT May Be Preferred

Shockwave therapy may be the better starting point when:

The condition has strong ESWT evidence – plantar fasciitis, lateral epicondylitis, calcific shoulder tendinitis, and Achilles tendinopathy all have robust RCT data supporting ESWT
Cost is a concern – ESWT typically costs less than PRP for a full treatment course
The patient prefers non-invasive treatment – no needles, no blood draw
Broader treatment areas – ESWT can cover a larger tissue area per session, which may benefit conditions affecting a wider zone
Multiple locations need treatment in the same visit

When PRP May Be Preferred

PRP may be the stronger option when:

ESWT has been tried without adequate response – PRP offers a different biological mechanism
The injury involves a partial tear – PRP’s direct delivery of growth factors may benefit structural damage
Surgical conditions where PRP is used as an adjunct to accelerate post-operative healing
Joint conditions (like mild osteoarthritis) where intra-articular injection is the primary delivery route
The provider has strong expertise with PRP preparation and standardized protocols

The Combination Approach

Some providers use ESWT and PRP sequentially. A common protocol starts with ESWT as the first-line regenerative treatment. If the response is partial after 3-5 sessions, PRP is considered as a next step. This approach uses the less expensive, non-invasive option first and reserves PRP for cases that need additional intervention.

The biological rationale for combining them is sound: ESWT increases blood flow and sensitizes the tissue, potentially creating a more receptive environment for the growth factors in PRP. However, research specifically studying the combination is still in its early stages.

If you’re weighing these options, a provider who offers both treatments can give you a condition-specific recommendation. Understanding how shockwave therapy works at the cellular level can also help you evaluate these choices.

The Bottom Line

ESWT and PRP are both legitimate regenerative treatments, but they aren’t interchangeable. Shockwave therapy has a broader evidence base for most tendinopathies, is less invasive, and costs less. PRP delivers growth factors more directly and may have advantages for certain injuries, particularly partial tears. Neither is universally better – the right choice depends on your diagnosis, treatment history, and provider expertise. Ask your provider which option has the strongest evidence for your specific condition.

References

Vetrano M, Castorina A, Vulpiani MC, Baldini R, Pavan A, Ferretti A. Platelet-rich plasma versus focused shock waves in the treatment of jumper’s knee in athletes. Am J Sports Med. 2013;41(4):795-803. PubMed
Shetty SH, Dhond A, Arora M, Deore S. Platelet-rich plasma has better long-term results than corticosteroids or placebo for chronic plantar fasciitis: randomized control trial. J Foot Ankle Surg. 2019;58(1):42-46. PubMed

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Shockwave therapy outcomes vary by individual and condition. Consult a qualified healthcare provider to determine if shockwave therapy is appropriate for your situation.